Source: Annual Congress 2008 - Asthma: growing understanding of influential factors
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Swierczynska, E. Nizankowska-Mogilnicka, P. Strek, A. Gielicz, M. Grzywacz, A. Szczeklik (Cracow, Poland). The course of aspirin-induced asthma may be helpful in predicting the type of response to aspirin. Eur Respir J 2008; 32: Suppl. 52, 1152

Member's Comments

No comment yet.

Related content which might interest you: Clinical relevance of anti-inflammatory treatment of rhinitis for the course and prognosis of allergic bronchial asthma Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control Year: 2007 Omalizumab therapy reduces asthma exacerbations in children with severe allergic (IgE-mediated) asthma irrespective of lung function at baseline Source: Annual Congress 2009 - Difficult asthma in children: diagnostic and therapeutic challenges Year: 2009 Early treatment response may predict long-term mepolizumab benefit in severe asthma Source: International Congress 2019 – Treatment of asthma with monoclonal antibodies Year: 2019 Suppression of FENO with observed inhaled corticosteroid therapy in severe asthma: is it a useful test in clinical practice? Source: ERJ Open Res, 5 (4) 00123-2019; 10.1183/23120541.00123-2019 Year: 2019 Omalizumab is effective in patients with severe persistent allergic asthma in a real-life setting irrespective of age Source: Annual Congress 2009 - Towards improving asthma control Year: 2009 Comparison of residual eosinophilic inflammation in the distal airway of patients with well-controlled asthma using different drug combinations of asthma treatment Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD Year: 2008 Add-on omalizumab therapy reduces clinically significant and severe asthma exacerbations, and improves FEV1 in patients with severe persistent allergic asthma irrespective of age Source: Eur Respir J 2005; 26: Suppl. 49, 48s Year: 2005 Omalizumab therapy reduces oral corticosteroid use in patients with severe allergic (IgE-mediated) asthma: European real-life experience Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009 Prediction of the risk of future exacerbations in patients with severe persistent allergic asthma Source: Annual Congress 2005 - Severe asthma: perception and management Year: 2005 Immunological effectiveness of atorvastatin in complex therapy of severe persistent bronchial asthma Source: Annual Congress 2009 - Persistent asthma: still an uncontrolled disease requiring new treatments strategies in 2009 Year: 2009 Clinical features and their link with asthma exacerbations amongst aspirin-induced asthmatics Source: Annual Congress 2010 - Asthma aspect of diagnosis and criteria for follow-up Year: 2010 Efficacy of inhaled heparin is effective in the treatment of acute exacerbation of asthma Source: Annual Congress 2007 - New drugs for asthma Year: 2007 Is antibiotic treatment during asthma exacerbation necessary ? Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies Year: 2017 Predictors of response to therapy with omalizumab in patients with severe allergic asthma–a real life study Source: International Congress 2017 – Monitoring asthma control Year: 2017 Basophil activation test as support for distinguishing between aspirin-induced asthma and allergic reaction to ASA Source: Annual Congress 2011 - Diagnosis and treatment of inflammatory respiratory diseases Year: 2011 The importance of early applying inhaled corticosteroids in patients with mild bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 57s Year: 2002 Effect of asthma and asthma medication on the prognosis of patients with COVID-19 Source: Eur Respir J, 57 (3) 2002226; 10.1183/13993003.02226-2020 Year: 2021 Is omalizumab response influenced by passive smoking in severe asthma? Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures Year: 2018 Clinical and functional effectiveness of atorvastatin in complex therapy of severe bronchial asthma Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches Year: 2009 Physicians judge add-on omalizumab therapy as an effective treatment for patients with severe persistent allergic asthma: a pooled analysis Source: Eur Respir J 2005; 26: Suppl. 49, 49s Year: 2005